Ebang International
EBON
Abits
ABTS
Digihost Technology
DGHI
FRMO CORP
FRMO
BIT Mining
BTCM
US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 0.832
- -0.025-2.92%
Trading Mar 28 10:44 ET
187.03MMarket Cap-1.70P/E (TTM)
0.854High0.830Low454.72KVolume0.850Open0.857Pre Close380.37KTurnover0.21%Turnover RatioLossP/E (Static)224.71MShares3.17952wk High8.24P/B182.13MFloat Cap0.30452wk Low--Dividend TTM218.82MShs Float51.375Historical High--Div YieldTTM2.82%Amplitude0.291Historical Low0.836Avg Price1Lot Size
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Sangamo Therapeutics Stock Forum
Sangamo Lands $100M+ Deals with Genentech, Astellas as Losses Shrink 62%
20 million dollars upfront, with an expected up to 1.3 billion dollar funding over 5 years based on progress.
Can anyone following this company shed some light on why their estimated revenue is 11m for a 472% increase?
$Getty Images (GETY.US)$
$B. Riley Financial (RILY.US)$
$FibroGen (FGEN.US)$
$Sangamo Therapeutics (SGMO.US)$
$Health in Tech (HIT.US)$
$Altus Power (AMPS.US)$
Complete list in the image.
Sandy Macrae, Sangamo's President and Chief Executive Officer is scheduled to present on Wednesday, March 12 at 12:00 p.m. Eastern. A live webcast of the presentation will be available here and on the Sangamo Therapeutics website in the Investors and Media section under Events. A replay of the presentation will be available for...
This week or next I'm thinking.
200$ million cash up front minimum.
No comment yet